nal von minden plans to produce 80 million rapid corona tests per month
Rapid corona testing is playing an increasingly important role in containing the pandemiceverywhere – even though the first vaccines are now in sight. The medical technology company nal von minden GmbH from Moers, Germany, is therefore doubling its production: 40 million rapid antigen tests are already being produced in November. By January, this figure is expected to rise to 80 million – every month!
"We are continuing to double our production of rapid corona tests because we want to help contain the pandemic," says Roland Meissner, Managing Director of nal von minden GmbH. The demand for the NADAL® Covid-19 antigen test is very high. For this reason, monthly production in November was already increased from 20 million rapid tests to 40 million. Now production capacity is being further expanded – and fast. The new goal: to make 80 million rapid corona tests available every month from January on. "Possibly infected individuals can be detected immediately with the help of the rapid tests and, thus, other people can be better protected against corona," emphasises Meissner.
Even though the first vaccines are now in sight and new hope is emerging that the pandemic will finally end, it will certainly take some time until all or most people are vaccinated. "Rapid tests continue to play a very important role, especially for the protection of those in at risk groups," says Meissner. The rapid tests are, therefore, primarily passed on to healthcare professionals such as geriatric nurses or doctors.
The NADAL® Covid-19 antigen test is performed on site and does not need to be sent to a laboratory. The result is available in just 15 minutes. For the test, a swab from the mouth or nasopharynx is taken by a medical professional. The antigen test detects specific viral components directly: the so-called nucleoprotein antigens. These proteins encapsulate the genetic material of Covid-19 viruses, which consists of ribonucleic acid (RNA).
The quality of the NADAL® Covid-19 antigen test has been repeatedly verified. Meissner: "The diagnostic specificity is over 99.9 percent, and the diagnostic sensitivity is 97.56 percent. The specificity provides information on whether all healthy people tested are recognised as being healthy. The sensitivity indicates whether all sick people are recognised as being sick.
+49 40 38 66 24 80
About nal von minden GmbH
Subscribe to releases from nal von minden GmbH
Subscribe to all the latest releases from nal von minden GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from nal von minden GmbH
Did my vaccine work? New rapid test for the determination of vaccination success25.5.2021 12:37:25 EEST | Press release
Am I really protected against the coronavirus now? This is a question asked by many after receiving a vaccination. The medtech company nal von minden from Moers in Germany has now developed a rapid test that can reliably detect antibodies against COVID-19 pathogens in blood. The NADAL® COVID-19 S1-NAb Test is now available all over Europe.
COVID-19: Use rapid tests to identify important biomarkers and predict the course of the disease7.1.2021 13:30:22 EET | Press release
Whether it’s a lung embolism or a heart attack – an infection with coronavirus can have life-threatening consequences. But how badly will different patients be affected by COVID-19? This can be determined by certain biomarkers. nal von minden GmbH’s biomarker rapid tests from Germany deliver reliable results in just 15 minutes.
Corona rapid test: Celebrate Christmas together without anyone getting infected15.12.2020 15:08:33 EET | Press release
In many places, uncertainty is now mixed in with the anticipation of Christmas: will Christmas be a “super spreader event” as many politicians are warning? “No”, Roland Meissner, the CEO of nal von minden in Moers, Germany is convinced: “you can protect your relatives as best as possible by getting tested for corona beforehand.” There are also tips to minimize the risk of corona during the actual festivities.
New study: Only reliable rapid corona tests make sense3.12.2020 13:21:25 EET | Press release
More and more manufacturers are bringing corona rapid tests onto the market. But only if they provide reliable results does their use in the fight against the pandemic makes sense. The Charité hospital in Berlin, one of the largest university hospitals in Europe, has now reviewed the performance of corona antigen rapid tests. The corona rapid test from nal von minden GmbH proved to be particularly reliable. The NADAL® COVID-19 Ag rapid test has already been used millions of times throughout Europe during the corona pandemic and provides a result within only 15 minutes.
New: Combined rapid test for Covid-19 and influenza2.11.2020 09:00:00 EET | Press release
Corona numbers are rising, and the next challenge is already in sight: Flu season is beginning. The symptoms can be very similar, but a test can differentiate between influenza and Covid-19. A new combined rapid test can detect coronavirus and influenza viruses simultaneously: The NADAL® COVID-19 Ag+Influenza A/B Test from German medical technology company nal von minden delivers a reliable result in just 15 minutes.
New Covid-19 antigen test: Fast and reliable results in just 15 minutes26.10.2020 09:07:47 EET | Press release
Preventing further spread of the coronavirus and taking pressure off laboratories – it is possible with the NADAL® Covid-19 Antigen Test from Germany. Whether in schools, nursing homes, hospitals, companies, or at the airport or larger events: The result is available in just 15 minutes. The new rapid test from medical technology company nal von minden GmbH is already approved in Europe and is available immediately. The high quality has been repeatedly verified.